DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Teva Announces Full FDA Approval of SYNRIBO® (Omacetaxine Mepesuccinate) for Injection

Novo Nordisk A/S's Brief Value Run Seems Over

Novo Nordisk has a fortress franchise in diabetes, but how much should investors pay for a fortress these days?

Insys Recovers From Stock Hit Tied To Fed Probe

Momenta Reports Wider Loss, Beats on Revenues - Analyst Blog

Will Teva Pharmaceutical Industries LTD Shares Wilt Under the Federal Microscope?

Teva is facing a federal investigation, at what could prove to be just the wrong time.

Early Morning Activity Shows Teva Pharmaceutical Industries (TEVA) Down

Will CoCrystal Discovery (Biozone) Be Dr. Phillip Frost's Next Successful Investment?

Can Teva's New CEO Turn Its Fortunes Around

3 Key Takeaways From Teva's Fourth Quarter

Let’s discuss 3 key takeaways from Teva’s fourth quarter earnings, and if rising competition in MS treatments from Novartis, Biogen, and Sanofi will eventually doom the company.

Teva Beats on Q4 Earnings & Revs, Affirms View - Analyst Blog